Abstract
Caffey disease, also known as infantile cortical hyperostosis, is a rare bone disease characterized by acute inflammation with swelling of soft tissues and hyperostosis of the outer cortical surface in early infancy. The common heterozygous mutation of the COL1A1 gene, p.Arg1014Cys, has been reported in patients with Caffey disease. However, its pathogenesis remains to be elucidated, and the reason for the incomplete penetrance and transient course of the disease is still unclear. In the present study, we performed mutation analysis of the COL1A1 and COL1A2 genes and measured bone mineral density in two Japanese familial cases of Caffey disease. The index case and two clinically healthy members of one family carry the common heterozygous mutation; in contrast, no mutation in COL1A1 or COL1A2 was identified in the affected members of the second family. In addition, we found normal bone mineral density in adult patients of both families who have had an episode of cortical hyperostosis regardless of the presence or absence of the common p.Arg1014Cys mutation. Conclusion: The results reveal that Caffey disease is genetically heterogeneous and that affected and unaffected adult patients with or without the common COL1A1 mutation have normal bone mineral density.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- MRI:
-
Magnetic resonance imaging
- NSAIDs:
-
Non-steroidal anti-inflammatory drugs
References
Borochowitz Z, Gozal D, Misselevitch I, Aunallah J, Boss JH (1991) Familial Caffey's disease and late recurrence in a child. Clin Genet 40:329–335. doi:10.1111/j.1399-0004.1991.tb03104.x
Cerruti-Mainardi P, Venturi G, Spunton M, Favaron E, Zignani M, Provera S, Dallapiccola B (2007) Infantile cortical hyperostosis and COL1A1 mutation in four generations. Eur J Pediatr 170:1385–1390. doi:10.1007/s00431-011-1463-0
Cho TJ, Moon HJ, Cho DY, Park MS, Lee DY, Yoo WJ, Chung CY, Choi IH (2008) The c.3040C > T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease). J Hum Genet 53:947–949. doi:10.1007/s10038-008-0328-5
Couper RT, McPhee A, Morris L (2001) Indomethacin treatment of infantile cortical periostosis in twins. J Paediatr Child Health 37:305–308. doi:10.1046/j.1440-1754.2001.00633.x
Cundy T (2012) Recent advances in osteogenesis imperfecta. Calcif Tissue Int 90:439–449. doi:10.1007/s00223-012-9588-3
Dalgleish R (1997) The human type I collagen mutation database. Nucleic Acids Research 25;181-187. http://www.le.ac.uk/genetics/collagen/index.html
Dutta S, Jain N, Bhattacharya A et al (2005) Infantile cortical hyperostosis. Indian Pediatr 42:64–66
Estes K, Nowicki M, Bishop P (2007) Cortical hyperostosis secondary to prostaglandin E1 therapy. J Pediatr 151:441. doi:10.1016/j.jpeds.2007.02.066
Fried K, Manor A, Pajewski M, Starinsky R, Vure E (1981) Autosomal dominant inheritance with incomplete penetrance of Caffey disease (infantile cortical hyperostosis). Clin Genet 19:271–274. doi:10.1111/j.1399-0004.1981.tb00708.x
Gensure RC, Mäkitie O, Barclay C, Chan C, Depalma SR, Bastepe M, Abuzahra H, Couper R, Mundlos S, Sillence D (2005) A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J Clin Invest 115:1250–1257. doi:10.1172/JCI200522760
Glorieux FH (2005) Caffey disease: an unlikely collagenopathy. J Clin Invest 115:1142–1144. doi:10.1172/JCI25148
Kamoun-Goldrat A, Martinovic J, Saada J, Sonigo-Cohen P, Razavi F, Munnich A, Merrer ML (2008) Prenatal cortical hyperostosis with COL1A1 gene mutation. Am J Med Genet A 146A:1920–1824. doi:10.1002/ajmg.a.32351
Kamoun-Goldrat A, le Merrer M (2008) Infantile cortical hyperostosis (Caffey disease): a review. J Oral Maxillofac Surg 66:2145–2150. doi:10.1016/j.joms.2007.09.007
Katz DS, Eller DJ, Bergman G, Blankenberg FG (1997) Caffey's disease of the scapula: CT and MR findings. AJR Am J Roentgenol 168:286–287. doi:10.2214/ajr.168.1.8976971
Letts M, Pang E, Simons J (1994) Prostaglandin-induced neonatal periostitis. J Pediatr Orthop 14:809–813
Ranganath P, Laine CM, Gupta D, Mäkitie O, Phadke SR (2011) COL1A1 mutation in an Indian child with Caffey disease. Indian J Pediatr 78:877–879. doi:10.1007/s12098-010-0339-z
Saatci I, Brown JJ, McAlister WH (1996) MR findings in a patient with Caffey's disease. Pediatr Radiol 26:68–70. doi:10.1007/BF01403711
Sanders DG, Weijers RE (1994) MRI findings in Caffey's disease. Pediatr Radiol 24:325–327. doi:10.1007/BF02012117
Saul RA, Lee WH, Stevenson RE (1982) Caffey's disease revisited. Further evidence for autosomal dominant inheritance with incomplete penetrance. Am J Dis Child 136:55–60. doi:10.1001/archpedi.1982.0390370058014
Suphapeetiporn K, Tongkobpetch S, Mahayosnond A, Shotelersuk V (2007) Expanding the phenotypic spectrum of Caffey disease. Clin Genet 71:280–284. doi:10.1111/j.1399-0004.2007.00768.x
Thometz JG, DiRaimondo CA (1996) A case of recurrent Caffey's disease treated with naproxen. Clin Orthop Relat Res 323:304–309
Ueda K, Saito A, Nakano H et al (1980) Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 97:834–836
Acknowledgments
This study was supported in part by grants-in-aid from the Ministry of Health, Labour, and Welfare (KH20Q007a-1) of Japan.
Conflict of interest
All the authors do not have anything to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kitaoka, T., Miyoshi, Y., Namba, N. et al. Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literature. Eur J Pediatr 173, 799–804 (2014). https://doi.org/10.1007/s00431-013-2252-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-013-2252-8